Using fecal transplants to treat Clostridium difficile is gaining popularity, according to a Scienceline report.
The data is encouraging: For the 325 cases treated with fecal transplants worldwide, almost 90 percent reported no relapse of C. difficile and no side effects. However, no randomized control trials have been done to test the treatment's efficacy. All studies up to this point have been observational.
Related Articles on Gastroenterology:
Study: Virtual Colonoscopy Increases Colon Cancer Screening Rates
Study: American Ginseng Prevents Colon Cancer
Study: Same-Day Bowel Cleansing Regimen Superior to Split-Dose Regimen for Afternoon Colonoscopy
The data is encouraging: For the 325 cases treated with fecal transplants worldwide, almost 90 percent reported no relapse of C. difficile and no side effects. However, no randomized control trials have been done to test the treatment's efficacy. All studies up to this point have been observational.
Related Articles on Gastroenterology:
Study: Virtual Colonoscopy Increases Colon Cancer Screening Rates
Study: American Ginseng Prevents Colon Cancer
Study: Same-Day Bowel Cleansing Regimen Superior to Split-Dose Regimen for Afternoon Colonoscopy